Tina Larson

President at RECURSION PHARMACEUTICALS, INC.

Net worth: 6 M $ as of 2024-03-30

49 year

50 connections

Health Technology

Consumer Services

Profile

Presently, Tina Larson occupies the position of President & Chief Operating Officer for Recursion Pharmaceuticals, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
RECURSION PHARMACEUTICALS, INC. CLASS A 0.31%	2024-03-20	639,982 ( 0.31% )	6 M $	2024-03-30

Tina Larson active positions

Companies	Position	Start
RECURSION PHARMACEUTICALS, INC.	President	2019-09-30
Revagenix , Inc. Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019.	Chairman	-

All active positions of Tina Larson

Former positions of Tina Larson

Companies	Position	End
ACHAOGEN	Corporate Officer/Principal	2018-05-31
Roche, Inc.	Corporate Officer/Principal	2016-03-31
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	-

See the detail of Tina Larson's experience

Training of Tina Larson

Colorado State University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tina Larson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
RECURSION PHARMACEUTICALS, INC.	Health Technology

Private companies	4
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology
Roche, Inc.
Revagenix , Inc. Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019.	Health Technology

See company connections